Abbott LaboratoriesvsVeradermics

ABT and MANE stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$104.71

Value $182B

-2.55%
ABT's page

MANE

Veradermics, Incorporated

$125.64

Value $5.3B

-1.88%
MANE's page

Abbott Laboratories (ABT) has a market value of $182B and Veradermics (MANE) $5.3B. Dividend yield: ABT 2.41%, MANE none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$182B

    MANE$5.3B

    ABT is 34 times MANE

  • Revenue, 12 months

    ABT$48.2B

    MANE–

  • Net income, 12 months

    ABT$4.7B

    MANE-$94M

  • Operating margin

    ABT13.8%

    MANE–

  • ROIC

    ABT6.3%

    MANE–

  • P/E

    ABT38.7

    MANE–

  • Dividend yield

    ABT2.4%

    MANE0.0%

    2.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-1.3%

MANE+232.8%

100200300

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesMANEVeradermics

Valuation

ABTMANE
Valuation
Price$104.71$125.64
Market value$182B$5.3B
Enterprise value (EV)$209B$4.5B
P/E38.7–
P/E, 5-year median33.7–
P/B3.66.7
EV/EBIT31.4–
Free cash flow yield3.7%–

Results and growth

ABTMANE
Results and growth
Revenue, 12 months$48.2B–
Net income, 12 months$4.7B-$94M
Free cash flow, 12 months$6.8B-$83M
Earnings per share, 12 months$2.69-$40.10
Revenue growth, year on year5.7%–
Revenue growth a year, past+5.1%over 5 years–
EPS growth a year, past+8.3%over 5 years–

Margins and returns on capital

ABTMANE
Margins and returns on capital
Gross margin56.9%–
Operating margin13.8%–
Net margin9.8%–
ROIC6.3%–
ROE9.1%-26.2%

Balance sheet

ABTMANE
Balance sheet
Cash$4.3B$798M
Total debt$31.2B$371.0K
Net debt / EBITDA3.3–
Interest cover6.7×–

Dividends and buybacks

ABTMANE
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or MANE

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Veradermics?

By market value, Abbott Laboratories ($182B) is about 34.3 times Veradermics ($5.3B), at today's prices.

Which pays the higher dividend, ABT or MANE?

The dividend yield at today's price is 2.41% for Abbott Laboratories and none for Veradermics. Over the last twelve months they paid $2.52 and – per share.

Which is the better investment, Abbott Laboratories or Veradermics?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.